266 related articles for article (PubMed ID: 10073307)
1. Prevention of perinatal herpes: prophylactic antiviral therapy?
Scott LL
Clin Obstet Gynecol; 1999 Mar; 42(1):134-48; quiz 174-5. PubMed ID: 10073307
[TBL] [Abstract][Full Text] [Related]
2. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection.
Hollier LM; Wendel GD
Cochrane Database Syst Rev; 2008 Jan; (1):CD004946. PubMed ID: 18254066
[TBL] [Abstract][Full Text] [Related]
3. Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.
Le Cleach L; Trinquart L; Do G; Maruani A; Lebrun-Vignes B; Ravaud P; Chosidow O
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009036. PubMed ID: 25086573
[TBL] [Abstract][Full Text] [Related]
4. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial.
Sheffield JS; Hill JB; Hollier LM; Laibl VR; Roberts SW; Sanchez PJ; Wendel GD
Obstet Gynecol; 2006 Jul; 108(1):141-7. PubMed ID: 16816068
[TBL] [Abstract][Full Text] [Related]
5. Update on antiviral therapy for genital herpes infection.
Geers TA; Isada CM
Cleve Clin J Med; 2000 Aug; 67(8):567-73. PubMed ID: 10946451
[TBL] [Abstract][Full Text] [Related]
6. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
[TBL] [Abstract][Full Text] [Related]
7. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women.
Andrews WW; Kimberlin DF; Whitley R; Cliver S; Ramsey PS; Deeter R
Am J Obstet Gynecol; 2006 Mar; 194(3):774-81. PubMed ID: 16522412
[TBL] [Abstract][Full Text] [Related]
8. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
[TBL] [Abstract][Full Text] [Related]
9. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.
Kimberlin DW; Baley J; ;
Pediatrics; 2013 Feb; 131(2):e635-46. PubMed ID: 23359576
[TBL] [Abstract][Full Text] [Related]
10. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
[TBL] [Abstract][Full Text] [Related]
12. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
[TBL] [Abstract][Full Text] [Related]
13. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
Leone P
Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
[TBL] [Abstract][Full Text] [Related]
14. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study.
Leruez-Ville M; Ghout I; Bussières L; Stirnemann J; Magny JF; Couderc S; Salomon LJ; Guilleminot T; Aegerter P; Benoist G; Winer N; Picone O; Jacquemard F; Ville Y
Am J Obstet Gynecol; 2016 Oct; 215(4):462.e1-462.e10. PubMed ID: 27083761
[TBL] [Abstract][Full Text] [Related]
15. Current recommendations for the treatment of genital herpes.
Leung DT; Sacks SL
Drugs; 2000 Dec; 60(6):1329-52. PubMed ID: 11152015
[TBL] [Abstract][Full Text] [Related]
16. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
17. Vertical transmission of genital herpes: prevention and treatment options.
Jones CA
Drugs; 2009; 69(4):421-34. PubMed ID: 19323586
[TBL] [Abstract][Full Text] [Related]
18. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.
Kimberlin DW; Baley J; ;
Pediatrics; 2013 Feb; 131(2):383-6. PubMed ID: 23378604
[No Abstract] [Full Text] [Related]
19. Genital herpes: antiviral therapy for symptom relief and prevention of transmission.
Gupta R; Wald A
Expert Opin Pharmacother; 2006 Apr; 7(6):665-75. PubMed ID: 16556084
[TBL] [Abstract][Full Text] [Related]
20. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes.
Scott LL; Sanchez PJ; Jackson GL; Zeray F; Wendel GD
Obstet Gynecol; 1996 Jan; 87(1):69-73. PubMed ID: 8532270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
